Background—The prognostic usefulness of troponin enzymes in end-stage renal disease
(ESRD) patients is controversial. To resolve this uncertainty of troponin as a prognostic tool …

Mortality among patients with ESRD remains high because of an excessive cardiovascular
risk related to a very high incidence of cardiac hypertrophy, cardiomyopathy, heart failure …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

ContextCardiac troponin T (cTnT) and C-reactive protein (CRP) are prognostic markers in
acute coronary syndromes. However, for patients with end-stage renal disease (ESRD) the …

Background—Patients with severe renal dysfunction often have unexplained elevated
serum concentrations of cardiac troponin T (cTnT). We investigated whether in vivo …

Background: Clinicians face uncertainty about the prognostic value of troponin testing in
patients with chronic kidney disease (CKD) without suspected acute coronary syndrome …

Background: In patients with end-stage renal disease (ESRD), the ability of single and
multiple biomarker monitoring to predict adverse outcomes has not been well established …

Cardiac disease is the leading cause of death in uremic patients. In contrast to previous
opinion, coronary events account for a relatively small proportion of cardiac deaths, the most …

Background: Serum cardiac troponin concentrations are commonly increased in end-stage
renal disease (ESRD) in the absence of an acute coronary syndrome (ACS). The data on …

The patient with chronic kidney disease and coronary artery disease (CAD) presents special
challenges. This report reviews the scope of the challenge, the hostile internal milieu …